Health Net |
Emgality (300 MG Dose) (galcanezumab-gnlm) |
Drugs for the Nervous System : Drugs for Migraine Headaches |
- Step Therapy: Migraine Prevention:
ST Multiple Generics
- Cluster Headache:
Age Requirement: >= 18
Duration: 3 Month(s)
Documented Diagnosis: Yes
Medical Test Required: No
Reauthorization Required: Yes
Duration of Reauthorization: = 12 month(s)
Migraine Prevention: Age Requirement: >= 18
Duration: 3 Month(s)
Documented Diagnosis: Yes
- Prior Authorization: Cluster Headache:
Documented Diagnosis: Yes
Age Requirement: >= 18
Duration: 3 Month(s)
Reauthorization Required: Yes
Migraine Prevention: Documented Diagnosis: Yes
Age Requirement: >= 18
Duration: 3 Month(s)
|